We then examined a second independent patient cohort of 118 patients with non‐high‐grade (low‐ and intermediate‐grade) DCIS, with or without associated early invasive cancer (stage 0 and stage I), for increased power in evaluation of TBX3 association with invasiveness of low‐grade breast cancers. Here, TBX3 is linked to breast carcinoma.